CrossRef Advancements, Strategies, and Challenges in Organoid-Based Drug Evaluation for Tissue Engineering and Regenerative Medicine Chengbin Xue, Fujia Sun, Hui Zhu, Jianfeng Shi, Jiaqi Wang, Qiuwen Sun, Muyuan Tong, Xiaosong Gu, Qianqian Han, Wei Shi Engineering .2026
70 SongX.ZhuZ.QianX.LiuX.ChenS.TangH
So, whether there is a kind of medicine whose effects can cover as many targets as possible is a good question for liver disease therapy
Regulatory uncertainty limits its medical positioning, currently placing it in the grey zone of experimental peptides These limitations make clinical endorsement premature, especially in regulated health systems or for medical-grade use